TILT-123

DB17519InvestigationalGene Therapies

TILT-123: Overview.

Mechanism: Pharmacologically active on Tumor necrosis factor and Interleukin-2
Curator reviewed
Also known as: Ad5/3-E2F-d24-hTNFa-IRES-hIL2
Code names: TILT-123

Resolves to

Targets

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with TILT-123, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.